drugset / Trial / NCT01069783
Study of A3309 in Patients With Dyslipidemia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this trial is to determine the efficacy and safety of A3309 administered to patients with dyslipidemia (high cholesterol levels).
Timeline
- Start
- 2010-02
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elobixibat | Small molecule | 2.5 mg | — |
| Subject | Elobixibat | Small molecule | 5 mg | — |